Navigating Clinical Trials for Exosome-Based Therapeutics: From Phase I to Approval
Time: 10:15 am
day: Day Two
Details:
• Reviewing the progression of exosome therapeutics from initial trials to market approval
• Focusing on patient selection and regulatory navigation to enhance trial design and improve early-stage success rates
• Utilizing strategic partnerships to accelerate development timelines
